Topographical features of the formation of outflow tracts with the use of spongy allo-drainages in glaucoma

Author:

Kornilaeva G. G.1ORCID,Musina L. A.1ORCID,Kornilaeva M. P.1ORCID,Shangina O. R.1ORCID

Affiliation:

1. Bashkir State Medical University (Russian Eye and Plastic Surgery Centre)

Abstract

PURPOSE. Improving the results of the operation and achieving its reliability in secondary glaucoma, including refractory glaucoma, can be done using a non-biodestructible allograft drainage with spongy structure fabricated by Alloplant® technology.METHODS. Experimental and morphological studies conducted in the Russian Eye and Plastic Surgery Center showed that the allogeneic spongy biomaterial used for anti-glaucoma sponge drainage surgery is gradually replaced by loose tissue with a porous structure, similar to trabecular, forming a new drainage system. During the operation, the proximal part of the drainage is inserted through the excised drainage zone in the anterior chamber angle (ACA). The distal part is tucked into the suprachoroidal space through a linear incision in the scleral bed.RESULTS. The newly created topography of the ACA after sponge drainage operation with the use of allogeneic biomaterial features not only the expansion of the ACA profile, but also the replacement of the excised part of the drainage zone with biomaterial after sinus trabeculectomy (STE) and elimination of retention of the intraocular fluid (IOF) outflow. Ultrasound biomicroscopy (UBM) performed at various times after antiglaucoma surgery showed that the microtubule system preserved. Optical coherence tomography (OCT) of the ACA demonstrates the location of the drainage in the long-term follow-up.CONCLUSION. Antiglaucoma operation with the use of allogeneic biomaterial with spongy structure promotes the formation of trabecula-like tissue in the ACA, eliminates retention of IOF outflow, and reduces the risk of scleroscleral and sclero-conjunctival adhesions.

Publisher

Research Institute of Eye Diseases

Reference19 articles.

1. Erichev V.P. Refractory glaucoma: treatment features. Vestnik Oftal’- mologii 2000; 116(5):8-10.

2. Astakhov Yu.S., Egorov E.A., Brezel Yu.A. Surgical treatment of refractory glaucoma. RMJ Clinical Ophthalmology 2006; 2(l):25-27.

3. Rascheskov A.Yu, Loskoutov I.A. Modern technologies of refractory glaucoma theatment. Review. Ophthalmology in Russia 2012; 9(1): 4-9. https://doi.org/10.18008/1816-5095-2012-1-54-62

4. National Glaucoma Guidelines for Medical Practitioners. Ed. Egorova E.A., Ericheva V.P. Moscow, GEOTAR-Media Publ., 2019. 384 p.

5. Isakov I.N., Kuroedov A.V. Profile of a patient with secondary glaucoma. National Journal Glaucoma 2022; 21(3):64-71. https://doi.org/10.53432/2078-4104-2022-21-3-64-71

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3